Skip to Content
Quarter-End Insights

Our Outlook for Health-Care Stocks

Mergers and acquisitions replace reform as a key health-care topic.

Mentioned: , , , , , , , , ,

<< Return to Main Market Outlook Page

  • The passage of the health-care reform completion didn't result in a sector rally despite its overall benign attributes.
     
  • Big Pharma performance was particularly weak in the quarter, primarily as a result of near-term noise. Industrywide trends and fundamentals are attractive, and stocks remain undervalued.
     
  • Mergers and acquisitions dominate the industry landscape. More consolidation is expected.

To view this article, become a Morningstar Basic member.

Register for Free

Alex Morozov does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.